Emergent BioSolutions Inc. (EBS)
NYSE: EBS · IEX Real-Time Price · USD
2.530
-0.060 (-2.32%)
At close: Mar 28, 2024, 4:00 PM
2.550
+0.020 (0.79%)
After-hours: Mar 28, 2024, 7:56 PM EDT
Emergent BioSolutions Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for EBS stock has a target of 5.00, which predicts an increase of 97.63% from the current stock price of 2.53.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for EBS stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 0 | 0 | 0 | 0 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 1 | 1 | 1 | 1 | 0 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Benchmark | Benchmark | Hold → Strong Buy Upgrades $5 | Hold → Strong Buy | Upgrades | $5 | +97.63% | Mar 7, 2024 |
JP Morgan | JP Morgan | Sell Initiates n/a | Sell | Initiates | n/a | n/a | Nov 20, 2023 |
Benchmark | Benchmark | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Aug 29, 2023 |
Benchmark | Benchmark | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +769.57% | May 31, 2023 |
Benchmark | Benchmark | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +769.57% | May 19, 2023 |
Financial Forecast
Revenue This Year
1.20B
from 1.05B
Increased by 13.98%
Revenue Next Year
1.14B
from 1.20B
Decreased by -4.93%
EPS This Year
1.56
from -14.85
EPS Next Year
3.71
from 1.56
Increased by 138.31%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.3B | 1.2B | 856.0M | 791.5M | 820.9M |
Avg | 1.2B | 1.1B | 823.4M | 761.3M | 789.6M |
Low | 1.2B | 1.1B | 798.9M | 738.7M | 766.2M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 19.5% | -1.2% | -24.7% | -3.9% | 7.8% |
Avg | 14.0% | -4.9% | -27.6% | -7.5% | 3.7% |
Low | 9.6% | -7.8% | -29.7% | -10.3% | 0.6% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 2.64 | 3.85 | -0.05 | -0.04 | -0.04 |
Avg | 1.56 | 3.71 | -0.05 | -0.04 | -0.04 |
Low | 0.56 | 3.60 | -0.05 | -0.04 | -0.04 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 147.7% | - | - | - |
Avg | - | 138.3% | - | - | - |
Low | - | 131.2% | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.